Shares of Resmed Inc. (RMD) traded over 7% higher in pre-market on Thursday morning after the company’s third-quarter ...

ResMed has a minority stake in Nyxoah who are developing a neurostimulation implant to treat OSA. Although we see little near-term risk from this therapy due to the higher cost and invasive surgery ...

Piper Sandler lowered the firm’s price target on ResMed (RMD) to $248 from $260 and keeps a Neutral rating on the shares. The firm notes the ...

Discover ResMed's Q3 2025 earnings highlights, including 8% revenue growth, margin expansion, new product launches, and strategic investments in ...

Resmed beat Wall Street estimates for third-quarter profit on Wednesday, driven by demand for its sleep apnea devices used to manage the common sleep disorder.

Resmed beat Wall Street estimates for third-quarter profit on Wednesday, driven by demand for its sleep apnea devices used to manage the common sleep disorder. The company manufactures continuous ...

Sleep patient volume growth was slower in the last 12 months but is expected to improve in the next 12 months, according to the 1Q25 HME Sleep and Oxygen Survey from Needham.

It may not seem obvious, but even your sleeping position (I’m a side sleeper), pillowcase, and pillow could play a role in wrinkle formation. More abrasive (and super common) pillowcase fabrics ...

That’s why Powershout invented The Shoutlet, a “portable voice suppression device” — that is, a small pillow made from high-density memory foam — to give everyone an outlet for their ...

The new limited-edition Pillow Talk Soulmates Collection features upgraded versions of brand bestsellers, including a face palette that we're predicting will sell out. Charlotte Tilbury Pillow ...

Home CPAP device maker Resmed is launching a small, disposable wearable to help diagnose cases of obstructive sleep apnea. The NightOwl testing device, about the size of a quarter, is worn on the ...